Features
News roundups
Announcements
Most Viewed      Most Discussed

PrEP is great at blocking HIV, but as its use grows, so do fears that people will be more sexually reckless and spread other STIs. But researchers are coming to think that the opposite could be true

Quick Read

When people living with HIV walk out of prison, they leave with up to a month’s worth of HIV medication in their pockets. What they don’t necessarily leave with is access to health care or the services that will keep them healthy in the long term

Quick Read

In the United States, pharmaceutical companies have built a system which supports high costs for HIV drugs. But that may be starting to change

Quick Read

An effort led by the Johns Hopkins Center for Communication Programs aims to combat the social and cultural stigmas that prevent some men in parts of Africa from knowing their HIV status

Quick Read

Improved treatment has nearly tripled viral suppression rates among HIV patients in the United States over the past two decades, researchers report. But viral suppression rates remain lower among young people and black Americans, the researchers add

Quick Read

Global health officials say, ‘They did it all wrong’

Quick Read

State financial regulators in New York said Wednesday that they would investigate reports that gay men have been denied insurance policies covering life, disability or long-term care because they were taking medication to protect themselves against HIV

Quick Read

Three years ago, Dr. Philip J. Cheng, a urology resident at Harvard’s Brigham and Women’s Hospital, nicked himself while preparing an HIV-positive patient for surgery. Following hospital protocol, he took a one-month course of Truvada, a cocktail of two anti-HIV drugs, to prevent infection. Later, because he was an unattached gay man, he decided to keep taking Truvada to protect himself from getting HIV through sex

Quick Read